127 results match your criteria: ""Tzaneion" General Hospital[Affiliation]"
Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine.
Eur J Gastroenterol Hepatol
November 1996
Gastroenterology Department, 'Tzaneion' General Hospital of Piraeus, Greece.
Objective: To compare the systemic load of 5-aminosalicylic acid (5-ASA) as a basis for potential long-term toxicity during treatment in usual dosage with olsalazine (Dipentum) and one controlled-release mesalazine preparation (Salofalk) in patients with inactive ulcerative colitis.
Design: Open, randomized, crossover study. TREATMENT SCHEDULE: Olsalazine 500 mg twice daily for 7 days and mesalazine 500 mg thrice daily for 7 days consecutively.
Characteristics of rectosigmoid adenomas as predictors of synchronous advanced proximal colon neoplasms.
Am J Gastroenterol
September 1996
Department of Gastroenterology, Tzaneion General Hospital of Piraeus, Greece.
Background/aim: Colonoscopy is recommended to every patient with adenoma in rectosigmoid to disclose synchronous proximal neoplasms. The aim of this study was to determine whether characteristics of rectosigmoid adenomas are associated with proximal advanced neoplasms.
Patients/methods: One hundred consecutive symptomatic patients who underwent total colonoscopy and had rectosigmoid adenomas were included in the study.